Forecast-beating profit lifts Charles River

• E-mail

E-mail this article
To:
Invalid E-mail address
Add a personal message:(80 character limit) Your E-mail:
Invalid E-mail address

Sending your article
Your article has been sent.

Charles River Laboratories International Inc., the seller of mice and rats used in laboratory experiments, gained the most in a month after reporting earnings that beat analyst estimates. Charles River climbed 3.9 percent to $35.23 at 4 p.m. in New York, the biggest increase since Jan. 10. The Wilmington, Massachusetts-based company reported earnings excluding one-time items of 69 cents a share, beating by 10 cents the average of 16 analyst estimates compiled by Bloomberg.

To continue, please sign up or log in to BostonGlobe.com

Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com

Sign up

Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.

Sign up

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription.

Start here

BostonGlobe.com subscriber

Click to continue reading this article or to log in to BostonGlobe.com.

• E-mail

E-mail this article
To:
Invalid E-mail address
Add a personal message:(80 character limit) Your E-mail:
Invalid E-mail address

Sending your article
Your article has been sent.